Clinical and genetic features of PKAN patients in a tertiary centre in Turkey
dc.authorid | 0000-0001-8414-4017 | |
dc.authorid | 0000-0001-5319-0547 | |
dc.authorid | 0000-0002-4221-4459 | |
dc.authorid | 0000-0002-0609-4269 | |
dc.authorid | 0000-0002-5790-6853 | |
dc.authorscopusid | 57189258386 | |
dc.authorscopusid | 36445791100 | |
dc.authorscopusid | 57207593418 | |
dc.authorscopusid | 57195390478 | |
dc.authorscopusid | 56200906700 | |
dc.authorscopusid | 57192665800 | |
dc.authorscopusid | 56376905000 | |
dc.authorwosid | Akcakaya, Nihan Hande/AAG-3089-2022 | |
dc.authorwosid | Battaloğlu, Esra/AAF-1559-2020 | |
dc.authorwosid | Gultekin, Murat/AAQ-5865-2020 | |
dc.authorwosid | Ozbek, Ugur/C-9513-2017 | |
dc.authorwosid | Bilir, Birdal/AAD-7656-2020 | |
dc.authorwosid | Gultekin, Murat/AAO-2604-2020 | |
dc.authorwosid | Hanagasi, Hasmet A./AAT-9501-2020 | |
dc.contributor.author | Akçakaya, Nihan Hande | |
dc.contributor.author | Uğur İşeri, Sibel | |
dc.contributor.author | Bilir, Birdal | |
dc.contributor.author | Battaloğlu, Esra | |
dc.contributor.author | Tektürk, Pınar | |
dc.contributor.author | Gültekin, Murat | |
dc.contributor.author | Yapıcı, Zuhal | |
dc.contributor.author | Alp, Recep | |
dc.date.accessioned | 2022-05-11T14:40:16Z | |
dc.date.available | 2022-05-11T14:40:16Z | |
dc.date.issued | 2017 | |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı | |
dc.description.abstract | Objective: Pantothenate kinase-associated neurodegeneration (PKAN) is caused by mutations of the pantothenate kinase 2 (PANK2) gene. The major clinical sign of PKAN is dystonia and the eye-of-the-tiger pattern on the MRI has been a clue for the diagnosis. We aim to discuss clinical and genetic findings of 22 PKAN patients from 13 families. Methods: Twenty-two patients were clinically diagnosed with PKAN and screened for PANK2 mutations. The patients were classified according to their onset age and progression rate. Results: Mutation screening revealed 5 novel and 7 previously reported sequence variants in PANK2. The variants identified were in the form of missense changes, small exonic deletions and intronic mutations with a probable splicing effect. The presenting features were dystonia and gait disturbance in early onset patients, whereas the presenting symptoms were variable for the late onset group. The progression rate of the disease was not uniform. Conclusion: The current report is the first patient series of PI(AN from Turkey that expands the clinical and genetic spectrum of the disease. (C) 2017 Elsevier B.V. All rights reserved. | |
dc.description.sponsorship | Scientific Research Projects Coordination Unit of Istanbul UniversityIstanbul University [51985]; Istanbul Development AgencyTurkiye Cumhuriyeti Kalkinma Bakanligi [TR10/15/YNK/0093] | |
dc.description.sponsorship | The authors are grateful to the patients and their relatives for their participation in this study. This work was supported by grants from the Scientific Research Projects Coordination Unit of Istanbul University, Project Number 51985, and the Istanbul Development Agency, Project Number TR10/15/YNK/0093. We thank the Advanced Genomics and Bioinformatics Research Centre (IGBAM), TUBITAK-BILGEM, for kindly providing the exome sequencing data of 350 individuals from Turkey with varying disorders, which were used as a population control set for the novel PANK2 mutations. We also thank Dr. Thomas Klopstock and Dr. Holger Prokisch for their help in enrolling the patients in the TIRCON study. | |
dc.identifier.doi | 10.1016/j.clineuro.2017.01.011 | |
dc.identifier.endpage | 42 | |
dc.identifier.issn | 0303-8467 | |
dc.identifier.issn | 1872-6968 | |
dc.identifier.pmid | 28113101 | |
dc.identifier.scopus | 2-s2.0-85009958038 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 34 | |
dc.identifier.uri | https://doi.org/10.1016/j.clineuro.2017.01.011 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/8920 | |
dc.identifier.volume | 154 | |
dc.identifier.wos | WOS:000396965600006 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Alp, Recep | |
dc.language.iso | en | |
dc.publisher | Elsevier Science Bv | |
dc.relation.ispartof | Clinical Neurology and Neurosurgery | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Pantothenate kinase 2 (PANK2) | |
dc.subject | Pantothenate kinase-associated | |
dc.subject | neurodegeneration (PKAN) | |
dc.subject | Neurodegeneration with brain iron | |
dc.subject | accumulation (NBIA) | |
dc.subject | Phenotype-genotype | |
dc.subject | Kinase-Associated Neurodegeneration | |
dc.subject | Brain Iron Accumulation | |
dc.subject | Hallervorden-Spatz-Syndrome | |
dc.subject | The-Tiger-Sign | |
dc.subject | Pank2 Gene | |
dc.subject | Mutations | |
dc.subject | Dystonia | |
dc.title | Clinical and genetic features of PKAN patients in a tertiary centre in Turkey | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 8920.pdf
- Boyut:
- 2.07 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text